comparemela.com

Latest Breaking News On - Yigal nochomovitz - Page 4 : comparemela.com

Arcus Biosciences, Inc. (NYSE:RCUS) Q4 2023 Earnings Call Transcript

Operator: Hello and welcome to the Arcus Biosciences Full Year/Q4 2023 Earnings Call. My name is Elliot, and I’ll be coordinating your call today. [Operator Instructions].

Japan
Juan-jaen
Terence-flynn
Bob-goeltz
Yigal-nochomovitz
Dimitry-nuyten
Jonathan-miller
Kaveri-pohlman
Terry-rosen
Salveen-richter
Johanna-mercier
Peter-lawson

3 Under-the-Radar Stocks With 340% to 762% Upside in 2024, According to Select Wall Street Analysts

If a trio of Wall Street analysts is correct, three lesser-known stocks could skyrocket in the new year.

France
French
Amit-dayal
Vernon-bernardino
Yigal-nochomovitz
Sk-group
Us-department-of-energy
Renault
Citigroup
Lexicon-pharmaceuticals
Drug-administration
Plug-power

This little-known oncology stock could jump more than 70%, Citi says

Olema Oncology could be a standout player in developing a breast cancer therapy, according to Citi Research.

Yigal-nochomovitz
Citi-research
Olema-oncology
Analyst-yigal-nochomovitz
Breaking-news-markets
Biotechnology
Olema-pharmaceuticals-inc
Stock-markets
Investment-strategy
Markets
Health-care-industry
Business-news

Forecasting The Future: 4 Analyst Projections For Macrogenics

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Macrogenics (NASDAQ:MGNX) in the last thre.

Yigal-nochomovitz
Charles-zhu
Robert-burns
Hc-wainwright-co
Macrogenics-inc
Health-care
Analyst-firm
Citigroup
Analyst-ratings
Know-macrogenics
Deep-dive
Capitalization-analysis

ProKidney Corp. (NASDAQ:PROK) Q3 2023 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to the ProKidney Corporate Update Conference Call. At this time, all lines are in a listen-only mode.

United-states
Framingham
Massachusetts
Chicago
Illinois
Canada
Calgary
Alberta
Americans
Pablo-legorreta
Darin-weber
Glenn-schulman

vimarsana © 2020. All Rights Reserved.